| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |